Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patients

Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance

(2011) Alberto Tosetto et al.   THROMBOSIS AND HAEMOSTASIS

Endothelial von Willebrand factor regulates angiogenesis

(2010) R. D. Starke et al.   BLOOD

The genetic basis of von Willebrand disease

(2010) Anne C. Goodeve   BLOOD REVIEWS

Homozygous type 2N R854W von Willebrand factor is poorly secreted and causes a severe von Willebrand disease phenotype

(2010) G. CASTAMAN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

How I treat von Willebrand disease

(2009) F. Rodeghiero et al.   BLOOD

Type 2M von Willebrand disease: a variant of type 2A?

(2009) J. BATLLE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD

(2008) G. Castaman et al.   BLOOD

Evidence-based diagnosis of type 1 von Willebrand disease: a Bayes theorem approach

(2008) A. Tosetto et al.   BLOOD

Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients

(2008) A. B. Federici et al.   BLOOD

Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)

(2008) U. BUDDE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS